TY - JOUR
KW - Male
KW - Humans
KW - Aged
KW - Female
KW - *Selective Serotonin Reuptake Inhibitors/adverse effects
KW - *Atrial Fibrillation/complications/drug therapy/epidemiology
KW - Case-Control Studies
KW - Anticoagulants/adverse effects
KW - Hemorrhage/chemically induced/epidemiology
AU - A. Rahman
AU - R. Platt
AU - S. Beradid
AU - J. Boivin
AU - S. Rej
AU - C. Renoux
AD - Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.
Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
Department of Pediatrics, McGill University, Montreal, Quebec, Canada.
Department of Psychiatry, McGill University, Montreal, Quebec, Canada.
Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.
Department of Medicine, McGill University, Montreal, Quebec, Canada.
AN - 38517440
BT - JAMA Netw Open
C2 - PMC10960200 Biogen, Boehringer Ingelheim, Merck, Nant Pharma, and Pfizer outside the submitted work. Dr Rej reported receiving a Clinician-Scientist Salary Award from Fonds de Recherche Quebec Sante; receiving grants from Mitacs; serving on a steering committee for AbbVie; and holding shares in Aifred outside the submitted work. No other disclosures were reported.
DO - 10.1001/jamanetworkopen.2024.3208
DP - NLM
ET - 2024/03/22
LA - eng
M1 - 3
N1 - 2574-3805
Rahman, Alvi A
Platt, Robert W
Beradid, Sarah
Boivin, Jean-François
Rej, Soham
Renoux, Christel
Journal Article
United States
JAMA Netw Open. 2024 Mar 4;7(3):e243208. doi: 10.1001/jamanetworkopen.2024.3208.
PY - 2024
SN - 2574-3805
EP - e243208
T2 - JAMA Netw Open
TI - Concomitant Use of Selective Serotonin Reuptake Inhibitors With Oral Anticoagulants and Risk of Major Bleeding
VL - 7
ER -